| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Glass John R is a See Remarks at PROVECTUS BIOPHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $10K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2017 | PVCT Provectus Biopharmaceuticals, Inc. | See Remarks | Buy | 200,000 | $0.05 | $10,791.59 | +237.8% |